🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David M. Weiss

Carl von Ossietzky Universität Oldenburg

ORCID: 0000-0001-5806-4144

Also affiliated with University of Kaiserslautern, Tel Aviv University, MaineHealth, Institute for Behavioral Medicine, Avaya (United States), The Ohio State University, Avaya (Bermuda)

Computer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia”.

Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia

Journal of Clinical Oncology(2020)10.1200/jco.20.00491

N/A

3.8DataRank · unranked

105 citations

Ying Huang, Amy S. Ruppert, Lynne V. Abruzzo, Barbara L. Andersen, Farrukh T. Awan +14 more

Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1130

N/A

3.1DataRank · unranked

79 citations

James S. Blachly, Kerry A. Rogers, Seema A. Bhat, Mojgan Jianfar, Gerard Lozanski +11 more

Using Experience Sampling Methodology Data to Characterize the Substance Use of Youth With or At-Risk of Psychosis

Frontiers in Psychiatry(2022)10.3389/fpsyt.2022.874246

N/A

0DataRank · unranked

4 citations

Elizabeth Bernier, Douglas R. Robbins, Katherine M. Elacqua, Kelsey A. Johnson, Kate Powers +3 more